By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Changing Fortunes in the Obesity Treatment Industry
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Devices > Changing Fortunes in the Obesity Treatment Industry
BusinessMedical DevicesNewsPublic Health

Changing Fortunes in the Obesity Treatment Industry

PatrickDriscoll
PatrickDriscoll
Share
2 Min Read
SHARE

With Qnexa, Contrave and Lorcaserin each recently rejuvenated after previous FDA’s near-death sentences, the market outlook for obesity drugs is now being viewed almost as optimistically as it was in 2010.

With Qnexa, Contrave and Lorcaserin each recently rejuvenated after previous FDA’s near-death sentences, the market outlook for obesity drugs is now being viewed almost as optimistically as it was in 2010.

Devices for the treatment of obesity are on the market, aggressively promoted (to a fault) and therefore driving revenue growth for manufacturers.  Much of this growth, however, comes in the vacuum left by clinical effective obesity drugs.  Devices are not without complications (see “1-800-GET-THIN”) and the need for surgery, even increasingly less invasive, is an impediment to more widespread use.  Long term data suggests a higher than anticipated need for repeat procedures, but this is not a significant disadvantage relative to obesity drugs, which must be taken indefinitely to maintain weight levels.

The global market for obesity drugs and devices will largely follow patterns in the Americas in general, or the U.S. in particular.  Below is illustrated the 2009 to 2019 market in the Americas for obesity drugs and devices, reflecting specific anticipated market developments (see report #S835) during that time.

More Read

bird flu infection
Human Infected with New Bird Flu Virus Investigated by Taiwan Scientists
Understanding RVUs | Medicare Reimbursement
Medicaid Expansion: How Does It Affect You?
What Happens After You Donate Your Body To Science?
Vaccines & Public Health in 2016: Where are We Now?

Source: “Products, Technologies and Markets Worldwide for the Clinical Management of Obesity, 2011-2019.” Report #S835, MedMarket Diligence, LLC

     

TAGGED:obesityobesity drugsobesity treatment
Share This Article
Facebook Copy Link Print
Share
By PatrickDriscoll
Follow:
I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses.Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025
AI in Healthcare
AI in Healthcare: Technology is Transforming the Global Landscape
Global Healthcare Policy & Law Technology
October 1, 2025
Choosing the Right Swimwear for Health and Safety
News
September 30, 2025
sports concussions
Concussion In Sports: How Common They Are And What You Need To Know
Infographics
September 28, 2025

You Might also Like

Tissue Engineering and Cell Therapy Market Outlook

May 23, 2014
BusinessPolicy & Law

Infographic:Pre-Reform Impact of Self-Pay Patients on US Hospitals

April 13, 2012

The Value of Connectivity in Healthcare

June 19, 2013
medicare rewards expansion
BusinessHealth ReformPolicy & LawPublic Health

Expansion of Medicare Rewards Adds Key Tool to Drive Behavior Change

October 2, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?